Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Acta haem al..?/: 303-309 (19b4). Fundación Hematológica M ar del Plata, Argentina Substitutive-Inhibitory Therapy in Constitutional Non-Spherocytic Erythrocytic Disease By E n r i q u e R e w a l d Although large tracks of population have not been investigated, there is no doubt about the extensive distribution of hemolytic diseases, specially due to the high incidence of abnormal hemo globins in M editerranean countries and in certain areas of Asia and Africa. The severity of the homozygous state induced inter esting speculations about the disappearance of some isolated communities (1). The difference between hypo- and hyper-regenerative anem ia is fundamental. W ith identical low Hb. concentration a patient is able to live norm ally (simple aplastic disease) or his activities are limited by easy fatigability (hyperactive erythropoiesis) (fig. 1). In adults, bone marrow volume is about 2.600 cc. (2), equal to 5/9 of blood volume. Normally, h alf of it is in activity with 6% of nucleated cells (3). Fat marrow can be replaced in a few days (4) due to the regenerative potential of hemopoiesis. C r o s b y a n d A k e r o y d (5) calculated that as
Acta Haematologica – Karger
Published: Jan 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.